Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of MXN 201.76 billion. The enterprise value is 29.28 billion.

Market Cap	201.76B
Enterprise Value	29.28B

Important Dates

The next estimated earnings date is Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.52%
Shares Change (QoQ)	-3.51%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	360.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.99
PB Ratio	0.89
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.39
EV / Sales	0.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.35

Financial Position

The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.

Current Ratio	3.67
Quick Ratio	3.45
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-164.38

Financial Efficiency

Return on equity (ROE) is -28.77% and return on invested capital (ROIC) is -18.44%.

Return on Equity (ROE)	-28.77%
Return on Assets (ROA)	-15.14%
Return on Invested Capital (ROIC)	-18.44%
Return on Capital Employed (ROCE)	-33.05%
Revenue Per Employee	11.63M
Profits Per Employee	-12.79M
Employee Count	5,800
Asset Turnover	0.20
Inventory Turnover	37.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-72.75%
50-Day Moving Average	627.44
200-Day Moving Average	1,089.51
Relative Strength Index (RSI)	41.19
Average Volume (20 Days)	3,758

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.50

Income Statement

In the last 12 months, Moderna had revenue of MXN 67.43 billion and -74.20 billion in losses. Loss per share was -193.37.

Revenue	67.43B
Gross Profit	-57.74B
Operating Income	-82.20B
Pretax Income	-75.16B
Net Income	-74.20B
EBITDA	-78.27B
EBIT	-82.20B
Loss Per Share	-193.37

Full Income Statement

Balance Sheet

The company has 146.38 billion in cash and 15.57 billion in debt, giving a net cash position of 182.79 billion.

Cash & Cash Equivalents	146.38B
Total Debt	15.57B
Net Cash	182.79B
Net Cash Per Share	n/a
Equity (Book Value)	227.15B
Book Value Per Share	588.47
Working Capital	122.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.60 billion and capital expenditures -21.90 billion, giving a free cash flow of -84.50 billion.

Operating Cash Flow	-62.60B
Capital Expenditures	-21.90B
Free Cash Flow	-84.50B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -85.63%, with operating and profit margins of -121.91% and -110.04%.

Gross Margin	-85.63%
Operating Margin	-121.91%
Pretax Margin	-111.46%
Profit Margin	-110.04%
EBITDA Margin	-116.07%
EBIT Margin	-121.91%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.52%
Shareholder Yield	-0.52%
Earnings Yield	-36.78%
FCF Yield	-41.88%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.29.

Altman Z-Score	7.29
Piotroski F-Score	n/a